Connecting People With Diabetes to Clinical Research That Matters

Review ongoing clinical trials, surveys, and research opportunities from trusted biotech and medical research partners.

Find us

Essex Junction, VT 0452, USA

Email us

ginger@diabetesnerd.com

,

Vertex Announces Two Deaths in VX-880 Clinical Trial

  • By Ginger Vieira
  • January 3, 2025
  • 322 Views

With tremendous empathy for their families, Vertex Pharmaceuticals announced two deaths in their VX-880 trial, including Brian Shelton, the first trial participant. While these deaths were not related to VX-880, further details have not been released out of respect for their privacy. The trial has been paused briefly for further investigation. The VX-264 trial will continue as planned. People with type 1 diabetes will always be grateful to these participants for contributing to this groundbreaking research.

Read more here: https://lnkd.in/esjKgz6A